Who invested in Iaso Therapeutics?
Iaso Therapeutics's investors include National Science Foundation, Michigan Rise, Red Cedar Ventures and National Institute of Allergy and Infectious Diseases.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$695Kraised across 2 rounds since 2023, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Filed with the SEC (Form D); no report of this raise yetSEC filing: $570K sold, first sale Jan 2026
Source recordedSEC filing: $438K sold, first sale Dec 2022
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Iaso Therapeutics's investors include National Science Foundation, Michigan Rise, Red Cedar Ventures and National Institute of Allergy and Infectious Diseases.
Iaso Therapeutics has raised $695K across 2 rounds since 2023.
Iaso Therapeutics's most recent round, $570K, was in Jan 2026.
Its most recent round, $570K in Jan 2026, is also its largest on record.
Iaso Therapeutics's first round on record, in Jan 2023, was backed by National Science Foundation, Michigan Rise and Red Cedar Ventures and 1 others.
Iaso Therapeutics's latest named round is a Grant, in Jan 2023.
Iaso Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.